| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
5,705 |
5,429 |
$3.47M |
| 99205 |
Prolong outpt/office vis |
378 |
362 |
$75K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
86 |
80 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
171 |
161 |
$0.00 |
| 98960 |
|
57 |
40 |
$0.00 |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
30 |
21 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15 |
15 |
$0.00 |
| 1033F |
|
13 |
12 |
$0.00 |
| 99386 |
|
19 |
17 |
$0.00 |
| 1000F |
|
12 |
12 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
409 |
404 |
$0.00 |
| 1220F |
|
218 |
216 |
$0.00 |
| 96415 |
|
24 |
17 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
57 |
56 |
$0.00 |
| 3008F |
|
57 |
57 |
$0.00 |
| 94760 |
|
14 |
14 |
$0.00 |
| 92250 |
|
38 |
38 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
27 |
27 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
17 |
12 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
30 |
22 |
$0.00 |